Mini Review
Published on 30 Mar 2023
mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1155728
- 7,061 views
- 6 citations
Type at least 3 characters
2,748 articles
Articles
Perspective
Published on 29 Mar 2023
Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1107266
- 2,537 views
- 3 citations
Original Research
Published on 29 Mar 2023
Integrated summary of immunogenicity of polatuzumab vedotin in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1119510
- 3,856 views
- 2 citations
Original Research
Published on 28 Mar 2023
Impact of BCG vaccination on the repertoire of human γδ T cell receptors
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1100490
- 2,313 views
- 1 citation
Original Research
Published on 28 Mar 2023
Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1130054
- 2,841 views
- 1 citation
Original Research
Published on 24 Mar 2023
Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1103765
- 5,239 views
- 3 citations
Review
Published on 23 Mar 2023
Glycan masking in vaccine design: Targets, immunogens and applications
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1126034
- 5,618 views
- 10 citations
Original Research
Published on 23 Mar 2023
Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1126392
- 5,460 views
- 5 citations
Original Research
Published on 23 Mar 2023
Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1138526
- 3,715 views
- 1 citation
Original Research
Published on 23 Mar 2023
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1139329
- 3,577 views
- 4 citations
Original Research
Published on 22 Mar 2023
Immune transgene-dependent myocarditis in macaques after systemic administration of adeno-associated virus expressing human acid alpha-glucosidase
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1094279
- 5,474 views
- 9 citations
Original Research
Published on 22 Mar 2023
Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1120010
- 2,922 views
- 9 citations
Original Research
Published on 22 Mar 2023
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1147028
- 4,426 views
- 3 citations
Original Research
Published on 21 Mar 2023
Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.961642
- 4,916 views
- 7 citations
Original Research
Published on 21 Mar 2023
Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1077938
- 3,185 views
- 4 citations
Original Research
Published on 20 Mar 2023
Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1154496
- 2,490 views
- 4 citations